Loading…
Based on limited metadata without access to the full letter text, the FDA issued a warning to Greenbrier International, Inc (operating as Dollar Tree) on November 6, 2019, regarding drug products. The specific violations cannot be detailed as the subject line information is unavailable, though the warning indicates compliance concerns with FDA drug regulations. As a major retailer, Dollar Tree likely faced issues related to the manufacture, distribution, or sale of drug products under their operations. Without the complete letter, the precise nature and scope of the violations cannot be accurately determined.